Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Mar;24(1):15-21.
doi: 10.6065/apem.2019.24.1.15. Epub 2019 Mar 31.

Screening and management of thyroid dysfunction in preterm infants

Affiliations

Screening and management of thyroid dysfunction in preterm infants

Hye Rim Chung. Ann Pediatr Endocrinol Metab. 2019 Mar.

Abstract

Preterm infants can suffer various thyroid dysfunctions associated with developmental immaturity of the hypothalamic-pituitary-thyroid axis, postnatal illness, medications, or iodine supply. The incidence of thyroid dysfunction among preterm infants is higher than that among term infants and has been increasing with improvement in the survival of preterm infants. Hypothyroxinemia is frequently observed during the first week of life in extreme preterm neonates, and the incidence of delayed thyrotropin elevation is high at the age of 2-6 weeks. Although the necessity of routine rescreening remains controversial, recent guidelines on screening for congenital hypothyroidism have recommended rescreening of all preterm neonates. Thyroid hormone replacement is recommended for persistent thyrotropin elevation with or without hypothyroxinemia. Hypothyroxinemia without thyrotropin elevation does not require treatment, and some potential risks of levothyroxine supplementation have been reported. Although most thyroid dysfunctions are transient, careful follow-up after discontinuation of levothyroxine is considered so as to avoid missing persistent hypothyroidism.

Keywords: Hypothyroidism; Hypothyroxinemiasequencing; Preterm infant; Short stature; Thyroid.

PubMed Disclaimer

References

    1. Dussault JH, Coulombe P, Laberge C, Letarte J, Guyda H, Khoury K. Preliminary report on a mass screening program for neonatal hypothyroidism. J Pediatr. 1975;86:670–4. - PubMed
    1. DH Lee. The prevalence of pediatric endocrine and metabolic diseases in Korea. Korean J Pediatr. 2008;51:559–63.
    1. Mitchell ML, Hsu HW; Massachusetts Pediatric Endocrine Work Group. Unresolved issues in the wake of newborn screening for congenital hypothyroidism. J Pediatr. 2016;173:228–31. e1. - PubMed
    1. American Academy of Pediatrics. Rose SR, Section on Endocrinology and Committee on Genetics. American Thyroid Association. Brown RS, Public Health Committee, Lawson Wilkins Pediatric Endocrine Society. Foley T, et al. Update of newborn screening and therapy for congenital hypothyroidism. Pediatrics. 2006;117:2290–303. - PubMed
    1. Léger J, Olivieri A, Donaldson M, Torresani T, Krude H, van Vliet G, et al. European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism. Horm Res Paediatr. 2014;81:80–103. - PubMed

LinkOut - more resources